Funded with Support from

Investigators compared improvements in visual outcomes between glasses treatment and no treatment in children with moderate bilateral astigmatism and normal vision.

This was the first prospective, randomized, multicenter study of repeated low-level red-light therapy for myopia control in children, a treatment currently approved in China for amblyopia.

Dr. Maria E. Aaron discusses pediatric ophthalmology and strabismus topics for comprehensive ophthalmologists.

In this population-based analysis, investigators evaluated ophthalmologic disorders associated with autism spectrum disorder.

This course covers information on diagnosis and management of ophthalmic problems encountered in everyday practice in Core Ophthalmic Knowledge for Pediatric Ophthalmology/Strabismus. Core ophthalmic knowledge is defined as necessary clinical knowledge expected of all ophthalmologists regardless of practice emphasis area.

This week, a gene therapy for Leber hereditary optic neuropathy gains orphan drug designation, a novel eye drop for presbyopia is cleared for phase 2 trials and a common antidepressant shows early promise for amblyopia.

Multicenter prospective, randomized amblyopia screening and treatment trials have created a new body of evidence upon which to base clinical practices of screening, diagnosis, and treatment. This collection of content, based on IRIS Registry measure IRIS50: Amblyopia: Interocular Visual Acuity, reviews the best evidence-based approach for diagnosing and treating amblyopia while advocating for early, appropriate screening.

Early diagnosis of ocular changes associated with amblyopia is crucial for good visual prognosis because it allows treatment to begin at a stage where the visual neurological pathways are still amenable to stimulation, recovery, and reversal of cortical damage.

Researchers assessed whether amblyopia affects self-perception in young children and correlates with defects in vision and fine motor skills.